血清免疫球蛋白G水平与慢阻肺急性加重风险相关:SPIROMICS分析
本研究基于SPIROMICS队列中1,497名现吸烟或已戒烟者(1,026例慢阻肺患者和471例有慢阻肺风险者),分析血清总IgG及亚类与前瞻性急性加重的关系。结果显示,IgG低于本队列第35百分位(1,225 mg/dl)与急性加重风险增加相关(IRR 1.28,95%CI 1.08-1.51),IgG1和IgG2低于各自第35百分位(354和105 mg/dl)与重度急性加重风险增加相关。最佳IgG截断值显著高于传统缺陷 cutoff,提示轻度体液免疫受损可能与急性加重相关。
要点
- 血清IgG低于1,225 mg/dl与慢阻肺急性加重风险增加相关(IRR 1.28)。
- IgG1低于354 mg/dl和IgG2低于105 mg/dl分别与重度急性加重风险增加相关。
- 最佳IgG截断值高于传统缺陷标准,提示亚临床免疫受损值得关注。
核心结论
- 较低的血清IgG水平与有慢阻肺或慢阻肺风险者的前瞻性急性加重相关。
- IgG1和IgG2较低分别与重度急性加重风险增加相关。
- 最佳IgG截断值显著高于传统缺陷 cutoff,提示轻度体液免疫受损可能与急性加重相关。
研究设计与样本
- SPIROMICS队列研究,纳入现吸烟或已戒烟者1,497例(慢阻肺1,026例,有慢阻肺风险471例)。
- 在1,031例子集中测量IgG亚类,采用多变量模型分析总IgG或亚类与前瞻性急性加重的关联,并校正人口学特征、当前吸烟、吸烟史、FEV1占预计值百分比、吸入糖皮质激素和血清IgA。
主要发现
- IgG第35百分位(本队列为1,225 mg/dl)为Akaike信息准则确定的最佳截断值,低于此值急性加重风险增加(IRR 1.28;95%CI 1.08-1.51)。
- IgG1低于第35百分位(354 mg/dl)与重度急性加重风险增加相关(IRR 1.39;95%CI 1.06-1.84)。
- IgG2低于第35百分位(105 mg/dl)与重度急性加重风险增加相关(IRR 1.50;95%CI 1.14-1.97)。
- 额外校正急性加重史后,上述关联仍显著。
关键数值与推荐
- 总IgG最佳截断值为1,225 mg/dl(本队列第35百分位),低于此值急性加重风险增加(IRR 1.28;95%CI 1.08-1.51)。
- IgG1第35百分位为354 mg/dl,低于此值重度急性加重风险增加(IRR 1.39;95%CI 1.06-1.84)。
- IgG2第35百分位为105 mg/dl,低于此值重度急性加重风险增加(IRR 1.50;95%CI 1.14-1.97)。
临床怎么用
- 对于现吸烟或已戒烟的慢阻肺患者及有慢阻肺风险者,可关注血清IgG水平以评估急性加重风险。
- 血清IgG低于1,225 mg/dl或IgG1、IgG2低于各自第35百分位时,提示急性加重或重度急性加重风险增加。
- 传统IgG缺陷 cutoff 可能低估与急性加重相关的轻度体液免疫受损,临床评估时需注意。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Serum IgG deficiency is associated with morbidity in chronic obstructive pulmonary disease (COPD), but it is unclear whether concentrations in the lower end of the normal range still confer risk. Objectives: To determine if levels above traditional cutoffs for serum IgG deficiency are associated with exacerbations among current and former smokers with or at risk for COPD. Methods: Former and current smokers in SPIROMICS (the Subpopulations and Intermediate Outcome Measures of COPD study) (n = 1,497) were studied: 1,026 with COPD and 471 at risk for COPD. In a subset (n = 1,031), IgG subclasses were measured. Associations between total IgG or subclasses and prospective exacerbations were evaluated with multivariable models adjusting for demographic characteristics, current smoking, smoking history, FEV1 percent predicted, inhaled corticosteroids, and serum IgA. Measurements and Main Results: The 35th percentile (1,225 mg/dl in this cohort) of IgG was the best cutoff by Akaike information criterion. Below this, there was increased exacerbation risk (incidence rate ratio [IRR], 1.28; 95% confidence interval [CI], 1.08-1.51). Among subclasses, IgG1 and IgG2 below the 35th percentile (354 and 105 mg/dl, respectively) were associated with increased risks of severe exacerbation (IgG1, IRR, 1.39; 95% CI, 1.06-1.84; IgG2, IRR, 1.50; 95% CI, 1.14-1.1.97). These associations remained significant when additionally adjusting for a history of exacerbations. Conclusions: Lower serum IgG is prospectively associated with exacerbations in individuals with or at risk for COPD. Among subclasses, lower IgG1 and IgG2 are prospectively associated with severe exacerbations. The optimal IgG cutoff was substantially higher than traditional cutoffs for deficiency, suggesting that subtle impairment of humoral immunity may be associated with exacerbations.
引用
- Burnim, Putcha, LaFon, et al. Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICS. Am J Respir Crit Care Med. 2025. PMID: 39441116. doi:10.1164/rccm.202311-2184OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。